section name header

Pronunciation ⬇

klox-a-SILL-in

Classifications ⬆ ⬇

Therapeutic Classification: anti-infectives

Pharmacologic Classification: penicillinase resistant penicillins

Indications ⬆ ⬇

REMS


Action ⬆ ⬇

  • Bind to bacterial cell wall, leading to cell death. Not inactivated by penicillinase enzymes.
Therapeutic effects:
  • Bactericidal action.

Spectrum:

Pharmacokinetics ⬆ ⬇

Absorption: IV administration results in complete bioavailability. Moderately absorbed (50%) following oral administration.

Distribution: Widely distributed; penetration into CSF is minimal but sufficient in the presence of inflamed meninges; crosses the placenta and enters breast milk.

Metabolism/Excretion: Some metabolism by the liver (9–22%) and some renal excretion of unchanged drug (20 %).

Half-Life: 0.5–1.1 hr (↑ in severe hepatic impairment, renal impairment, and in neonates).

Time/Action Profile ⬆ ⬇

ROUTEONSETPEAKDURATION
PO30 min30–120 min6 hr
IMunknownunknown6 hr
IVrapidend of injection/infusion6 hr

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Interactions ⬆ ⬇

Drug-drug:

Drug-Food:

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

Assessment ⬆ ⬇

Lab Test Considerations:

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆